Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months.
Cohen, Lawrence B
Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. [electronic resource] - Gastrointestinal endoscopy May 2005 - 650-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0016-5107
10.1016/s0016-5107(04)02835-4 doi
Belgium
Canada
Device Approval--standards
Endoscopy, Digestive System
Enzyme Inhibitors--therapeutic use
Equipment Safety
Esophagus--physiopathology
Female
Follow-Up Studies
Gastric Acid--metabolism
Gastroesophageal Reflux--drug therapy
Humans
International Cooperation
Male
Manometry
Middle Aged
Patient Satisfaction
Polyvinyls--administration & dosage
Pressure
Prognosis
Prostheses and Implants
Prosthesis Implantation--instrumentation
Proton Pump Inhibitors
Quality of Life
Time Factors
Treatment Outcome
United States
United States Food and Drug Administration
Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. [electronic resource] - Gastrointestinal endoscopy May 2005 - 650-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0016-5107
10.1016/s0016-5107(04)02835-4 doi
Belgium
Canada
Device Approval--standards
Endoscopy, Digestive System
Enzyme Inhibitors--therapeutic use
Equipment Safety
Esophagus--physiopathology
Female
Follow-Up Studies
Gastric Acid--metabolism
Gastroesophageal Reflux--drug therapy
Humans
International Cooperation
Male
Manometry
Middle Aged
Patient Satisfaction
Polyvinyls--administration & dosage
Pressure
Prognosis
Prostheses and Implants
Prosthesis Implantation--instrumentation
Proton Pump Inhibitors
Quality of Life
Time Factors
Treatment Outcome
United States
United States Food and Drug Administration